p53 expression in cytology samples may represent a marker of early‐stage cancer
Cancer Cytopathology · 2023-06 · 131 (6) · 392-401
DOI: 10.1002/cncy.22694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 27.03.2023. Verfasst von Federica Policardo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Background
TP53 gene plays a major role in the negative control of cell proliferation and in the regulation of signaling cascades. TP53 mutation may have a relevant role in the malignant transformation of thyroid cells as well as thyroid tumor progression. TP53 mutation has been detected only in few well differentiated thyroid carcinomas and is absent in benign conditions.
Methods
A total of 162 prospective thyroid cytology and corresponding histological samples diagnosed from atypia of indeterminate significance (AUS) to malignant, were studied via immunocytochemistry for p53. Hence, 50 benign lesions (B) were used as negative control. Molecular analysis for p53 only was performed.
Results
The cytology resulted in 50 B, 48 AUS, 40 follicular neoplasms (FNs), 23 suspicious for malignancy (SFM), and 1 malignant (M) case. The authors reported 102 negative and 60 positive p53 cases. The 60 positive cases included 27 cases with weak and/or focal cytoplasmic positivity (+1) and 33 with cases moderate (2+) to strong (3+) cytoplasmic and/or nuclear expression. Overall, 71 cases had histology (2 B, 11 AUS, 37 FN, 20 SFM, and 1 M) including 61.7% benign and 38.2% malignant diagnoses. Only 16 of 71 (5 FN, 10 SFM, and 1 M) were p53‐positive. Furthermore, 100% AUS and 86.5% FN cases were p53‐negative, none of which had malignant histology. All p53‐positive cases were associated with a larger nodule size, tall‐cell variant subtype, multifocality, extra thyroidal infiltration, and nodal metastases. Noninvasive follicular thyroid neoplasm with papillary like nuclear features were negative for p53. Few discrepancies in p53 intensity were observed on histology; there were no differences with the molecular testing. Conclusions p53 might be useful in discriminating thyroid follicular lesions. p53 is likely to be a useful diagnostic marker in recognizing indeterminate lesions that are well‐differentiated thyroid cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Anatomic Pathology and Histology, Catholic University of Sacred Hearth, Rome, Italy.
- Division of Endocrinology, Catholic University, Rome, Italy.
- Division of Endocrine-Surgery, Fondazione Policlinico Universitario "Agostino Gemelli"-IRCCS, Rome, Italy.
- Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Francesco Pierconti, Liron Pantanowitz, Esther Diana Rossi
Förderung
- Italian Ministry of Health
Zitieren
APA
Policardo, F., Tralongo, P., Arciuolo, D., Fiorentino, V., Cardasciani, L., Pierconti, F., Carlino, A., Curatolo, M., Pontecorvi, A., Fadda, G., De Crea, C., Lombardi, C. P., Raffaelli, M., Larocca, L. M., Pantanowitz, L., & Rossi, E. D. (2023). p53 expression in cytology samples may represent a marker of early‐stage cancer. Cancer Cytopathology, 131(6), 392-401. https://doi.org/10.1002/cncy.22694
Vancouver
Policardo F, Tralongo P, Arciuolo D, Fiorentino V, Cardasciani L, Pierconti F, et al. p53 expression in cytology samples may represent a marker of early‐stage cancer. Cancer Cytopathology. 2023;131(6):392-401. doi:10.1002/cncy.22694
BibTeX
@article{Policardo2023,
author = {Policardo, Federica and Tralongo, Pietro and Arciuolo, Damiano and Fiorentino, Vincenzo and Cardasciani, Lina and Pierconti, Francesco and Carlino, Angela and Curatolo, Mariangela and Pontecorvi, Alfredo and Fadda, Guido and De Crea, Carmela and Lombardi, Celestino Pio and Raffaelli, Marco and Larocca, Luigi Maria and Pantanowitz, Liron and Rossi, Esther Diana},
title = {p53 expression in cytology samples may represent a marker of early‐stage cancer},
journal = {Cancer Cytopathology},
year = {2023},
volume = {131},
number = {6},
pages = {392--401},
doi = {10.1002/cncy.22694}
}
EUVIMED